Lack of significant toxicity after mirtazapine overdose: A five-year review of cases admitted to a regional toxicology unit

Clinical Toxicology

Volumn 45, Issue 1, 2007, Pages 45-50

  Waring, W Stephen ^a   Good, Alison M ^a   Bateman, D Nicholas ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Drug toxicity; Electrocardiograph; Safety monitoring

Indexed keywords

ACETYLCYSTEINE; ALCOHOL; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; COCODAMOL; CYPROHEPTADINE; LORAZEPAM; MIRTAZAPINE; NEUROLEPTIC AGENT; OPIATE; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; CLINICAL FEATURE; CONSCIOUSNESS LEVEL; DRUG MONITORING; DRUG OVERDOSE; DRUG SAFETY; DRUG USE; ELECTROCARDIOGRAPHY; HOSPITAL ADMISSION; HUMAN; HYPOTHERMIA; LABORATORY TEST; PNEUMONIA; PREDICTION; REFERENCE VALUE; RHABDOMYOLYSIS; SIDE EFFECT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, TRICYCLIC; FEMALE; HUMANS; MALE; MIANSERIN; MIDDLE AGED; OVERDOSE; POISON CONTROL CENTERS; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; TACHYCARDIA; UNCONSCIOUSNESS;

EID: 33847028449     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650601005837     Document Type: Article

References (31)

1. de Boer TH, Maura G, Raiteri M, de Vos CJ, Wieringa J, Pinder RM. Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology 1988; 27:399-408.
2. Davis R, Wilde MI. Mirtazapine: a review of its pharmacology and therapeutic potential in the management of major depression. CNS Drugs 1996; 5:389-402.
3. Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy 1997; 17:10-21.
4. Holm KJ, Markham A. Mirtazapine: a review of its use in major depression. Drugs 1999; 57:607-631.
5. Kasper S, Zivkov M, Roes KC, Pols AG. Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline. Eur Neuropsychopharmacol 1997; 7:115-124.
6. Amini H, Aghayan S, Jalili SA, Akhondzadeh S, Yahyazadeh O, Pakravan-Nejad M. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial. J Clin Pharm Ther 2005; 30:133-138.
7. Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM Jr. Mirtazapine vs. Paroxetine Study Group. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry 2002; 10:541-550.
8. Konstantinidis A, Stastny J, Ptak-Butta J, Hilger E, Winkler D, Barnas C, Neumeister A, Kasper S. Intravenous mirtazapine in the treatment of depressed inpatients. Eur Neuropsychopharmacol 2002; 12:57-60.
9. Biswas PN, Wilton LV, Shakir SA. The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England. J Psychopharmacol 2003; 17:121-126.
10. Luo S, Michler K, Johnston P, Macfarlane PW. A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol 2004; 37(Suppl):81-90.
11. Winokur A, Sateia MJ, Hayes JB, Bayles-Dazet W, MacDonald MM, Gary KA. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study. Biol Psychiatry 2000; 48:75-78.
12. Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM 2003; 96:369-374.
13. Bailey B, Buckley NA, Amre DK. A meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose. J Toxicol Clin Toxicol 2004; 42:877-888.
14. MHRA recent advice on SSRIs. (Accessed September 27, 2005, at http://medicines.mhra.gov.uk/ourwork/monitorsafequalmed/;safetymessages/ SSRI61204ddl.pdf)
15. Combes A, Peytavin G, Theron D. Conduction disturbances associated with venlafaxine. Ann Intern Med 2001; 134:166-167.
16. Peano C, Leikin JB, Hanashiro PK. Seizures, ventricular tachycardia, and rhabdomyolysis as a result of ingestion of venlafaxine and lamotrigine. Ann Emerg Med 1997; 30:704-708.
17. Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 2004; 42:67-71.
18. Khalifa M, Daleau P, Turgeon AJ. Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther 1999; 291:280-284.
19. Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm 2005; 2:125-131.
20. Hoes MJ, Zeijpveld JH. First report of mirtazapine overdose. Int Clin Psychopharmacol 1996; 11:147.
21. Langford NJ, Ferner RE, Patel H, Munyame C, Hamlyn AN. Mirtazepine overdose and miosis. J Toxicol Clin Toxicol 2003; 41:1037-1038.
22. Holzbach R, Jahn H, Pajonk FG, Mahne C. Suicide attempts with mirtazapine overdose without complications. Biol Psychiatry 1998; 44:925-926.
23. Velazquez C, Carlson A, Stokes KA, Leikin JB. Relative safety of mirtazapine overdose. Vet Hum Toxicol 2001; 43:342-344.
24. Raja M, Azzoni A. Mirtazapine overdose with benign outcome. Eur Psychiatry 2002; 17:107.
25. Garlipp P, Bruggemann BR, Machleidt W. A non-fatal mirtazapine overdose in a suicide attempt. Aust N Z J Psychiatry 2003; 37:244-245.
26. Gerritsen AW. Safety in overdose of mirtazapine: a case report. J Clin Psychiatry 1997; 58:271.
27. Retz W, Maier S, Maris F, Rosler M. Non-fatal mirtazapine overdose. Int Clin Psychopharmacol 1998; 13:277-279.
28. Kuliwaba A. Non-lethal mirtazapine overdose with rhabdomyolysis. Aust N Z J Psychiatry 2005; 39:312-313.
29. Khandat AB, Nurnberger JI Jr, Shekhar A. Possible mirtazapine-induced rhabdomyolysis. Ann Pharmacother 2004; 38:1321.
30. Wenzel S, Aderjan R, Mattern R, Pedal I, Skopp G. Tissue distribution of mirtazapine and desmethylmirtazapine in a case of mirtazapine poisoning. Forensic Sci Int 2006; 156:229-236.
31. Ciuna A, Andretta M, Corbari L, Levi D, Mirandola M, Sorio A, Barbui C. Are we going to increase the use of antidepressants up to that of benzodiazepines? Eur J Clin Pharmacol 2004; 60:629-634.